
High Standards · Traceability · Scalability
Thov hu rau Xi'an Sonwu Biotech Co., Ltd. rau txhua yam khoom koj xav tau.
Dab tsi yog terlipressin
Terlipressin hmoovyog ib qho ruaj khov, hluavtaws peptide analogue ntawm vasopressin. Raws li qhov zoo tshaj plaws derivative ntawm ib txwm tshwm sim vasoactive peptides, nws muaj cov qauv hloov pauv molecular uas ua rau muaj kev ruaj ntseg zoo dua qub thiab lub sijhawm ntev ntawm kev ua, ua rau nws muaj txiaj ntsig hauv kev tshawb fawb tshuaj thiab kev tsim kho. Cov khoom no pab txhawb rau hemodynamic stability thiab modulates circulatory physiology los ntawm influencing lub zos cov ntshav txaus faib thiab tswj vascular tone nyob rau hauv lub visceral cheeb tsam. Nws yog ib qho tseem ceeb heev rau cov txheej txheem physiological uas cuam tshuam nrog kev ncig thiab cov kua dej sib npaug, vim nws tseem ua lub luag haujlwm hauv kev tswj cov kua dej metabolism thiab tswj cov homeostasis. Vim nws stability, zoo compatibility, thiab dav applicability, nws yog haum rau ntau yam kev tshawb fawb tshuaj thiab formulation tshuab. Leveraging nws cov receptor tshwj xeeb-binding zog thiab ruaj khov physicochemical zog, nws yog zoo-tsim nyob rau hauv lub teb ntawm vasoactive peptides. Nws tseem yog ib lub ntsiab lus tseem ceeb hauv kev tshawb fawb thiab kev txhim kho. Yog tias koj xav paub ntau ntxiv txog Terlipressin acetate hmoov tsum, hu rau Xi'an Sonwu Biotech Co., Ltd.

Certificate Of Analysis
|
Yam khoom |
Specification |
Kev tshwm sim |
|
Qhov tshwm sim |
Dawb rau tawm -dawb crystalline hmoov |
Ua raws |
|
Assay |
98.0-102.0% |
99.7% |
|
Solubility |
Dawb soluble hauv dej thiab ethanol, me ntsis soluble hauv chloroform |
Ua raws |
|
Kev Ntsuas Kev Ntsuas |
HPLC Retention Time RT sib tw siv (± 2%) |
Ua raws |
|
FTIR Spectrum Matches siv spectrum |
Ua raws |
|
|
UV-Vis (max) 275nm (hauv methanol) |
Ua raws |
|
|
Yam khoom muaj feem |
Impurity A: Tsawg dua lossis sib npaug li 1.0% |
Ua raws |
|
Impurity B: Tsawg dua lossis sib npaug rau 0.5% |
Ua raws |
|
|
Tag nrho impuritie: Tsawg dua lossis sib npaug li 2.0% |
Ua raws |
|
|
Cov ntsiab lus dej |
Tsawg dua lossis sib npaug li 3.0% |
1.6% |
|
Cov hlau hnyav |
||
|
Raws li |
Tsawg dua lossis sib npaug li 2.0ppm |
Ua raws |
|
Cd |
Tsawg dua lossis sib npaug li 3.0ppm |
Ua raws |
|
Pb |
Tsawg dua lossis sib npaug li 5.0ppm |
Ua raws |
|
Microbial |
||
|
Tag nrho cov phaj suav |
Tsawg dua lossis sib npaug li 1000cfu / g |
Ua raws |
|
Poov & Pwm |
Tsawg dua lossis sib npaug li 100cfu / g |
Ua raws |
|
Escherichia Coli muaj nyob |
Tsis zoo |
Ua raws |
|
Salmonella |
Tsis zoo |
Ua raws |
|
Xaus |
Ua raws li Enterprise Standard |
|
terlipressin muag
Xi'an Sonwu Biotech Co., Ltd yog peptide raw khoom muag nrog peptide thev naus laus zis ntawm nws cov tub ntxhais thiab kev lag luam thoob ntiaj teb kev taw qhia. Sonwu tshwj xeeb hauv R & D, ntau lawm, thiab thoob ntiaj teb cov khoom siv peptides thiab polypeptide raw khoom. Sonwu cov khoom lag luam tau siv dav hauv ntau lub teb, suav nrog kev tsim cov leeg nqaij, kev zoo nkauj thiab tiv thaiv - laus, plaub hau noj qab haus huv, tswj qhov hnyav, nootropics, thiab cov khoom siv tshuaj.
Sonwu cov khoom tau siv dav hauv cov neeg siv khoom 'R & D thiab kev lag luam kev lag luam thoob ntiaj teb. Raws li qhov no, Sonwu tau txais kev tawm tswv yim ntau ntawm Sonwu cov khoom. Yog li ntawd, yog tias koj xav tau Terlipressin acetate hmoov, thov hu rau Xi'an Sonwu.
Xi'an Sonwu tsis tsuas yog muab cov kev pabcuam loj - teev ntau lawm tab sis kuj tseem tuaj yeem muab cov qauv pob khoom rau cov neeg siv khoom ua ntej.
|
Daim ntawv |
Tus Qauv Zauv |
Yam tsawg kawg nkaus |
|
Hmoov |
1g |
1g |
Cov neeg siv khoom zoo lus

Kev Pabcuam OEM
Xi'an Sonwu tsis tsuas yog muab cov khoom siv siab - zooTerlipressin hmoovtab sis kuj muaj cov khoom customized raws li cov neeg siv khoom xav tau.
Ua ntej, rau cov khoom lag luam customized, cov neeg siv khoom yuav tsum tau muab cov ntaub ntawv xws li cov khoom siv CAS tus lej thiab cov txheej txheem sib txuas. Sonwu yuav pab koj xyuas seb qhov kev hloov kho puas ua tau raws li koj qhov yuav tsum tau ua, lossis Sonwu yuav muab cov lus qhia tshaj lij.
Thib ob, hais txog kev ntim khoom customized, Sonwu cov khoom muaj nyob rau hauv qhov ntim tsawg kawg nkaus ntawm 1g, thiab Sonwu tuaj yeem muab cov ntim ntim raws li cov neeg siv khoom thov.

Dab tsi yog terlipressin siv rau
1. Kev tswj ntawm Portal Venous Circulation thiab Balance ntawm Vascular Tone
Nws muaj cov khoom vasoactive tshwj xeeb, ua rau nws ua haujlwm ntawm lub visceral microcirculatory system; nws modulates lub contractile lub xeev ntawm intra- plab vascular du nqaij, tswj cov ntshav txaus faib nyob rau hauv portal vein ceg, thiab optimizes hemodynamic txoj kev nyob rau hauv lub visceral cheeb tsam. Piv nrog rau cov tshuaj endogenous tshwm sim, cov khoom sib xyaw no nthuav tawm ntau dua molecular stability thiab lub sijhawm ntev ntawm kev ua, ua rau cov lus teb zoo dua hemodynamic. Nws pab txhawb rau cov kev cai ntawm lub cev lub cev uas cuam tshuam nrog portal venous siab thiab pab tswj cov dynamic tshuav ntawm visceral organ perfusion. Hepatic dysfunction feem ntau yog nrog los ntawm kev hloov pauv hauv portal venous flow dynamics uas tuaj yeem cuam tshuam cov hlab ntshav ruaj khov; los ntawm kev hloov pauv cov ntshav khiav nrawm thiab kev faib tawm- thiab tswj cov visceral circulatory txoj hauv kev- cov tshuaj no txo cov kev pheej hmoo ntawm kev hloov pauv hauv vascular siab. Nws cov kev ua ub no feem ntau yog concentrated nyob rau hauv lub visceral vasculature, nrog rau cov kev txwv ntawm cov hlab ntsha los yog hauv nruab nrab; ntsuas kev xaiv thiab kev ruaj ntseg ntawm lub cev, nws ua haujlwm raws li vasoactive peptide koom nrog hauv kev tswj hwm visceral vascular homeostasis.
2. Kev tswj lub raum Metabolic thiab Kev Saib Xyuas Dej -Salt Homeostasis
Raws li peptide muab los ntawm vasopressin, nws nthuav tawm cov yam ntxwv ua haujlwm zoo ib yam li cov tshuaj hormones endogenous; Nws ua haujlwm ntawm cov chaw tswj hwm hauv lub raum khaws cov ducts los hloov cov dej thiab electrolyte metabolism, yog li tswj xyuas qhov txheeb ze ntawm lub cev osmolality. Cov tshuaj no cuam tshuam rau hauv lub raum microcirculation, yog li txhim kho lub raum cov ntshav thiab cov metabolism hauv lub cev, ua kom yooj yim rau kev thauj mus los thiab tshem tawm cov metabolites, thiab txhawb nqa lub raum lub cev lub cev. Thaum cov kev hloov pauv hauv visceral ncig ua hem lub cev cov kua dej sib npaug - feem ntau nrog kev hloov pauv hauv cov dej faib thiab cov electrolyte concentrations - cov khoom sib xyaw pab kho cov metabolism tsis txaus thiab tswj cov txheeb ze ruaj khov ntawm dej thiab ntsev faib. Tsis tas li ntawd, vim nws qhov ruaj khov physicochemical zog thiab cuam tshuam tsawg kawg nkaus ntawm cov qauv cellular, nws leverages nws biocompatibility kom ua raws li lub cev muaj zog, ua kom muaj kev tswj hwm kev noj qab haus huv hauv cov zis metabolic kom tswj tag nrho lub cev kua homeostasis.

3. Kev tswj cov kab mob hauv lub cev thiab cov hlab ntsha hemodynamic tshuav
Nws ua rau cov kab mob peripheral vascular tone system rau qee yam, koom nrog kev tswj hwm ntawm vasomotor xwm txheej thiab cuam tshuam rau lub hauv paus vascular tsis kam; Nws yog li no pab txhawb rau kev saib xyuas thiab kev tswj hwm ntawm physiological fluctuations hauv ntshav siab. Nws feem ntau yog tsom rau splanchnic vasculature, tsis ncaj qha cuam tshuam rau lub ntiaj teb hemodynamic kev faib tawm los ntawm kev hloov pauv hauv lub cev thiab pab tswj cov ntshav ntws mus rau lub cev tseem ceeb xws li lub plawv, ntsws, thiab ob lub raum. Piv nrog rau cov tshuaj muaj zog vasoactive, nws qhov kev ua haujlwm yog maj mam maj mam- txo qhov kev pheej hmoo ntawm kev hloov pauv ntawm hemodynamic tsis txaus- thiab txhawb nqa kev saib xyuas ntawm cov hlab ntshav sib npaug. Nws kuj tseem ua lub luag haujlwm hauv kev tswj hwm microcirculatory muaj nuj nqi, txo qis kev mob plawv los ntawm hemodynamic fluctuations, thiab pab tswj kom muaj kev ruaj ntseg tag nrho cov hlab ntsha. Nrog rau nws lub sijhawm ntev ntawm kev ua haujlwm, nws pab txhawb rau kev ua haujlwm ntawm homeostasis ntawm qib tshuab, ua tus sawv cev tswj hwm ntawm cov vasoactive peptides.
Terlipressin mechanism ntawm kev txiav txim
1. Mechanism ntawm Visceral Vascular Regulation
Leveraging nws polypeptide molecular qauv, nws khi rau cov receptors tshwj xeeb ntawm cov cell membranes ntawm visceral vascular du leeg hlwb. Los ntawm kev koom tes hauv intracellular signal transduction thiab modulating lub contractile atherosclerosis ntawm cov nqaij mos hlwb, nws tswj cov vascular tone nyob rau hauv lub plab viscera. Cov tshuaj ua pov thawj xaiv receptor affinity, nyiam ua yeeb yam ntawm cov hlab ntsha cuam tshuam nrog lub mesenteric thiab portal venous systems thaum muaj kev cuam tshuam ncaj qha rau cov hlab ntsha thiab lub hlwb; Yog li ntawd, nws modulates lub contractile lub xeev ntawm visceral capacitance hlab ntsha thiab hloov cov ntshav ntws hauv zos. Nws cov qauv hloov kho confers txhim khu kev ruaj ntseg thiab lub sij hawm ntev ntawm kev ua nyob rau hauv vivo piv rau ntuj vasopressin, uas ua rau ib tug gradual hloov nyob rau hauv vascular tone thiab pab tswj hemodynamic stability. Qhov no mechanism modulates ntshav txaus faib nyob rau hauv lub visceral microcirculation thiab influences portal hemodynamics, li no mitigating fluctuations nyob rau hauv lub zos vascular kuj; Txawm li cas los xij, nws tag nrho cov txiaj ntsig tseem yog cov txheej txheem kev tswj hwm lub cev muaj txiaj ntsig zoo los ntawm receptor-nyob ntawm kev xaiv.
2. Cov txheej txheem tswj dej thiab ntsev metabolism
Terlipressin, peptide structurally analogous rau vasopressin, ua rau cov chaw receptor tshwj xeeb cuam tshuam nrog lub raum khaws cov ducts. Nws modulates intracellular osmotic signaling pathways, yog li cuam tshuam cov txheej txheem physiological tswj cov dej reabsorption. Los ntawm receptor- cov txheej txheem kho kom haum, nws cuam tshuam rau kev thauj mus los ntawm aquaporins. Nws hloov cov dej permeability ntawm lub raum tubules, yog li modulating dej reabsorption thiab pab tswj lub dynamic equilibrium ntawm lub cev kua osmolality. Tsis tas li ntawd, nws tuaj yeem cuam tshuam ncaj qha rau kev thauj cov electrolytes xws li sodium thiab potassium, yog li ua rau kev tswj hwm ntawm ionic gradients. Vim muaj kev hloov kho cov qauv, nws nthuav tawm cov kev tiv thaiv zoo rau enzymatic degradation, uas ua rau muaj kev cuam tshuam cov teeb liab ntau dua piv rau endogenous vasopressin thiab txhawb kev ruaj ntseg ntau dua hauv kev tswj cov dej thiab ntsev metabolism. Nws qhov kev nqis tes ua suav nrog kev hloov pauv ntawm lub raum dej thiab kev thauj mus los ntawm electrolyte es tsis yog kev hloov pauv hloov pauv, thiab nws ua lub luag haujlwm tseem ceeb hauv kev tswj lub cev kua dej homeostasis.

3. Mechanism ntawm Systemic Circulatory Homeostasis Regulation
Los ntawm leveraging cov yam ntxwv ntawm cov kab mob vascular receptors, nws tuaj yeem hloov kho peripheral vascular tsis kam mus rau qee yam, yog li ua rau kev tswj hwm ntawm lub cev tag nrho hemodynamic faib. Nws qhov chaw tseem ceeb ntawm kev ua yog splanchnic vasculature; los ntawm kev tswj hwm vasoconstriction hauv zos, nws tsis ncaj qha cuam tshuam rau cov kab mob hauv lub cev tsis zoo, ua kom muaj kev hloov pauv hloov pauv hauv cov ntshav ntws ntawm cov khoom nruab nrog cev. Cov tshuaj cov txheej txheem kev taw qhia muaj qhov pib maj mam, zam kev hloov pauv sai sai ntawm cov ntshav ntws; Qhov no ua rau muaj kev hloov pauv hemodynamic zoo, uas pab tswj cov hlab plawv system stability. Tsis tas li ntawd, los ntawm kev hloov kho cov kev tso tawm suab ntawm endogenous vasoactive yam tseem ceeb, nws kuj tseem tuaj yeem koom nrog hauv kev tswj hwm kev tawm tswv yim, yog li cuam tshuam ncaj qha rau hemodynamic tshuav nyiaj li cas. Zuag qhia tag nrho, qhov txheej txheem no feem ntau ua haujlwm los ntawm kev tswj hwm ntawm vascular tone thiab circulatory tis- dua li cov txheej txheem unidirectional ntawm kev txhim kho lossis kho - tuav lub cev tseem ceeb rau kev saib xyuas cov kab mob hauv lub cev muaj zog sib npaug.
Hoobkas
Xi'an Sonwu Biotech Co., Ltd. tau tsim ib lub tshuab ua tiav platform npog peptide molecular tsim, kev cai synthesis, precision purification, kev txheeb xyuas cov qauv, thiab kev tswj kom zoo. Ua raws li cov qauv kev tswj hwm zoo thoob ntiaj teb, lub tuam txhab ua kom nws cov khoom siv peptide ua tau raws li qhov siab -kawg raw khoom yuav tsum tau ntawm cov neeg muas zaub txawv teb chaws rau purity, stability, thiab batch sib xws.
Saib mus rau yav tom ntej, Sonwu yuav txuas ntxiv mus tob zuj zus peptide thev naus laus zis tshiab, nthuav Sonwu txoj kev koom tes thoob ntiaj teb, thiab siv zog los ua ib tus neeg ntseeg siab, ntev -lub sij hawm peptide raw khoom tov tus khub rau cov neeg siv khoom thoob ntiaj teb.


Daim ntawv pov thawj

CERES

HACCP

HALAL

ISO9001

ISO 14001

ISO 22000
Ntim

Logistics

Ntxiv nrog rau kev ua kom cov khoom zoo, lwm qhov tseem ceeb tshaj plaws yog lav kev xa khoom zoo rau Sonwu cov neeg siv khoom. Yog li ntawd, Xi'an Sonwu muaj ntau yam kev xaiv xa khoom raws li kev xav tau ntau yam.

FAQ
1. Cov kev kho mob twg yog Terlipressin feem ntau siv?
Thawj qhov qhia tau yog Hom 1 Hepatorenal Syndrome (HRS-1), siv los kho lub raum tsis ua haujlwm uas ua rau lub siab tsis ua haujlwm; Nws kuj tau qhia rau kev kho hemostatic ntawm ruptured esophageal varices thiab yuav siv tau rau kev tswj ntawm hypotension unresponsive rau norepinephrine.
2. Terlipressin yog ib tug prodrug; nws muaj qhov zoo li cas?
Raws li ib tug prodrug, nws undergoes qeeb metabolism hauv lub cev kom tso tawm nws active Cheebtsam, yog li zam tsis txhob muaj kev phiv xws li spiky nyob rau hauv cov ntshav siab. Nyob rau tib lub sijhawm, nws tsim kom muaj kev ruaj ntseg thiab khov kho cov nyhuv kav ntev li 3 mus rau 4 teev, muab cov tshuaj kho mob ruaj khov rau kev kho mob.
Yog tias koj tab tom nrhiav rau Terlipressin acetate hmoov tsum, hu rau Xi'an Sonwu. Nyem rau email, thiab tom qab ntawd koj tau txais siab - zooTerlipressin hmoov.
Email:sales02@sonwu.com
Cim npe nrov: Terlipressin hmoov, Tuam Tshoj terlipressin hmoov manufacturers, lwm tus neeg, Hoobkas






